Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Nov 13, 2015 · 10-Q · 44 days after period end · 0001193125-15-376834
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $414.61K | $18.72K |
| Net Income | -$3.92M | -$2.02M |
| EPS Diluted | -$0.10 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end
